Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Janssen Pharmaceuticals (Nucynta franchise)

Janssen Pharmaceuticals (Nucynta franchise)
M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Oral analgesic tablets for chronic pain in adults. The drug is an oral analgesic indicated for the management of moderate to severe chronic pain in adults when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 1125 Trenton Harbourton Road
  • 1125 Trenton-Harbourton Road
  • Hopewell Township, NJ 08560
  • United States

Janssen Pharmaceuticals (Nucynta franchise) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Janssen Pharmaceuticals (Nucynta franchise)‘s full profile, request access.

Request full access to PitchBook

Janssen Pharmaceuticals (Nucynta franchise) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Janssen Pharmaceuticals (Nucynta franchise)‘s full profile, request access.

Request full access to PitchBook